Fig. 1 | State of the art of eV biogenesis and dissemination in the extracellular space
不同的细胞外囊泡亚型以及各自的特征:可以看到这里主要的区别手段是size与marker不同
image-20220422191015381
Box 1 | EV 生成: 关键问题与挑战
How do we consider the whole complexity of the cell, including regulation of intracellular trafficking and cell metabolism in the study of extracellular vesicle (ev) biogenesis?
since ev biogenesis is also dependent on interaction with neighbouring cells and matrix in vivo,to which extent doe sthe ‘EV secretome’ change depending on environmental cues?
are distinct subsets of exosomes with different functions associated with multivesicular endosome (Mve) subpopulations?
what are the processes that turn subpopulations of Mves into secretory organelles?
How do chemical parameters, such as pericellular pH, concentration of reactive oxygen species and osmotic pressure, as well as physical constrains of the tissue, such as mechanical pressure due to cell density or stiffening extracellular matrix, affect intraluminal vesicle generation and secretion and plasma membrane budding?
Are processes described in vitro relevantin vivo?
From a more practical perspective, when aiming to interfere with ev biogenesis, how can we consider the complexity and diversity of the biogenesis of subpopulations of evs as well as the cell types, culture conditions and level of expression of ev cargoes? For instance, a given pathway, such as ceramide production, may inhibit exosome secretion of one subtype but not of others, while simultaneously affecting other regulatory processes in the cell. Moreover, if the inhibition or impairment of a specific process affects Mve biogenesis, given that not all Mves are secretory, new approaches are needed to clearly distinguish correlation and causality of the importance of the given process during exosome secretion.
Fig. 2 | The dynamics of eVs in extracellular space leading to their uptake and functions in recipient cells
Box 2 | 胞外空间的动态性: 关键问题与挑战
what is the interrelationship between extracellular vesicles (evs) and the extracellular matrix?
are all evs capable of crossing all basement membranes and, if not, is there tissue subpopulation specificity?
Given the importance of the extracellular matrix in the maintenance of normal tissue function, how do mechanical forces and the local matrix composition influence ev–extracellular matrix interaction?
to what extent does the composition of the extracellular matrix modulate the composition, and hence function, of evs?
what types of evs interact with the extracellular matrix, and is release of specific subpopulations into the extracellular matrix directly dependent on plasma membrane–matrix interactions and the associated mechanical forces?
Do evs carry components/properties that allow them to resist degradation extracellularly and to avoid undesirable interactions with non-target cells, matrix constituents and other interstitial factors?
How important are the biophysical properties of evs (for example, their size and compressibility) in traversing through the complex extracellular microenvironment?
after traversing the extracellular matrix, evs, or at least a subpopulation thereof, appear to have the capacity to cross several biological barriers. is this capability influenced by specific pathological situations (for example, the increase in vascular permeability)?
Do specific cell types interact with evs more efficiently, and does this interaction differ between different ev subpopulations?
Most of our understanding ofthe fate of EVsin vivo comesfrom studies using exogenously administered evs. However, ev isolation, storage, method of formulation and labelling may affect their targeting specificity and ultimate fate. thus, are the results obtained using exogenously administered evs representative of the physiological fate of endogenously generated evs?
Multiple approaches have been used to assessthe biodistribution of EVs in vivo, including fluorescent labelling of lipids and proteins, immunofluorescence, bioluminescence, Pet, sPeCt, Mri and Ct imaging59. all of these approaches have limitations in tracking the fate of evs, and novel approaches with large dynamic ranges of both temporal and spatial resolution are required to overcome these.
Functional delivery of extracellular vesicle cargo
which extracellular vesicle (ev)-associated factors are critical for dictating function (defined by signal-induction and/or cell entry)?
Can we define the rules that govern ev targeting, and can we manipulate this knowledge in future translational studies using ev-based medicines?
to what extent is the nature of the protein corona controlled by the native ev composition and how important is the corona in determining interactions with recipient cells or whole systems?
How do we overcome the technical challenge of small ev size and scarcity of cargo, posing issues on directimaging of functional delivery of cargo by native EVs in vivo?
are different ev subpopulations processed differently in recipient cells and do they exert different cellular functions? Can this heterogeneity be addressed by studying ev subpopulations individually, or do they cooperate in a synergistic manner?
How do we provide direct evidence that observed physiological effects are truly ev mediated and, if so, what ev cargoes are responsible? in this regard, an overlooked aspect is the relative contribution of evs compared to other communication means such as cell–cell contact, nanotubes orsoluble factorslike cytokines or extracellular rNa.
when attempting to dissect the relative potency of evs in directing cell communication from other secretome constituents, how important are the different non-vesicular secreted factors, such as extracellular matrix proteins and cytokines, in co-operation with evs in dictating the final and complex cellular response?